These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 28093257)

  • 41. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome.
    Vogel Ciernia A; Yasui DH; Pride MC; Durbin-Johnson B; Noronha AB; Chang A; Knotts TA; Rutkowsky JR; Ramsey JJ; Crawley JN; LaSalle JM
    Hum Mol Genet; 2018 Dec; 27(23):4077-4093. PubMed ID: 30137367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.
    Wang IT; Reyes AR; Zhou Z
    Neurobiol Dis; 2013 Oct; 58():3-12. PubMed ID: 23659895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome.
    Adachi M; Autry AE; Covington HE; Monteggia LM
    J Neurosci; 2009 Apr; 29(13):4218-27. PubMed ID: 19339616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs.
    Leoncini S; De Felice C; Signorini C; Zollo G; Cortelazzo A; Durand T; Galano JM; Guerranti R; Rossi M; Ciccoli L; Hayek J
    Oxid Med Cell Longev; 2015; 2015():421624. PubMed ID: 26236424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
    Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
    Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Gsk3b Reduces Nfkb1 Signaling and Rescues Synaptic Activity to Improve the Rett Syndrome Phenotype in Mecp2-Knockout Mice.
    Jorge-Torres OC; Szczesna K; Roa L; Casal C; Gonzalez-Somermeyer L; Soler M; Velasco CD; Martínez-San Segundo P; Petazzi P; Sáez MA; Delgado-Morales R; Fourcade S; Pujol A; Huertas D; Llobet A; Guil S; Esteller M
    Cell Rep; 2018 May; 23(6):1665-1677. PubMed ID: 29742424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
    Kao FC; Su SH; Carlson GC; Liao W
    Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.
    Ehrhart F; Coort SL; Cirillo E; Smeets E; Evelo CT; Curfs LM
    Orphanet J Rare Dis; 2016 Nov; 11(1):158. PubMed ID: 27884167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral Characterization of MeCP2 Dysfunction-Associated Rett Syndrome and Neuropsychiatric Disorders.
    Chin EWM; Goh ELK
    Methods Mol Biol; 2019; 2011():593-605. PubMed ID: 31273723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
    Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes.
    Kerr B; Soto C J; Saez M; Abrams A; Walz K; Young JI
    Eur J Hum Genet; 2012 Jan; 20(1):69-76. PubMed ID: 21829232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
    Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
    Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
    Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity and MeCP2-dependent regulation of nNOS levels in enteric neurons.
    Wahba G; Schock SC; Cudd S; Grynspan D; Humphreys P; Staines WA
    Neurogastroenterol Motil; 2016 Nov; 28(11):1723-1730. PubMed ID: 27254746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation.
    Du F; Nguyen MV; Karten A; Felice CA; Mandel G; Ballas N
    Hum Mol Genet; 2016 May; 25(9):1690-702. PubMed ID: 26908602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome.
    Ure K; Lu H; Wang W; Ito-Ishida A; Wu Z; He LJ; Sztainberg Y; Chen W; Tang J; Zoghbi HY
    Elife; 2016 Jun; 5():. PubMed ID: 27328321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
    Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
    J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.